Oritain hits half a billion, but faces Companies Office scrutiny

Oritain hits half a billion, but faces Companies Office scrutiny
Grant Cochrane and director John Key discuss counterfeiting issues. (Image: Oritain)
Brent Melville
Dunedin company Oritain, which specialises in origin tracing and is valued at $558 million, may have to disclose its earnings.Last week, the biotech firm completed a US$57m (NZ$90m) raise, in a series C round led by London venture capital firm Highland Europe, which valued it at just over half a billion dollars.But while its foundation is about traceability, the firm's earnings remain opaque. It doesn’t report its financials in NZ, despite "officially" being overseas owned from December 2021. Under the Companies Ac...

More Finance

UPDATED: ASB, ANZ offered settlement in class action stoush
Finance

UPDATED: ASB, ANZ offered settlement in class action stoush

ANZ immediately rejected the offer as a "stunt".

Pattrick Smellie 16 Jul 2025
Aussie fintech InDebted buys NZ firm Debtworks
Finance

Aussie fintech InDebted buys NZ firm Debtworks

Debtworks’ 44 staff will be absorbed into InDebted and clients will be carried over.

John Anthony 14 Jul 2025
Auckland Future Fund to announce global manager
Finance

Auckland Future Fund to announce global manager

Goodbye term deposits, hello diversified global equities. 

Oliver Lewis 11 Jul 2025
Critic says Govt 'missing the point' on AML
Finance

Critic says Govt 'missing the point' on AML

Critic says problems with AML/CFT come down to how rules have been interpreted.

Dileepa Fonseka 08 Jul 2025